Categories: CareCauseHardwareHealthTechMedtechTechnology
Conkay Medical has developed a device to treat valvular regurgitation in patients with progressive heart failure. Utilizing annular repair technology, the device addresses the main cause of functional regurgitation while preserving healthy valve leaflets. This innovation helps healthcare professionals improve cardiovascular care.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.03.2024 | Seed | $1.8M | - |
Mentions in press and media 5
| Date | Title | Description |
| 16.09.2024 | ConKay Medical Systems Adds Top Cardiologist to Advisory Board, Moves to Larger Headquarters | ConKay’s technology will greatly expand the population of patients who can be treated for tricuspid regurgitation.”
— Dr. Paul SorajjaPLEASANTON, CA, UNITED STATES, September 16, 2024 /EINPresswire.com/ -- ConKay Medical Systems, a medtech ... |
| 20.03.2024 | ConKay Medical Systems Secures $1.8M in Seed Funding | ConKay Medical Systems, a medtech start-up from Pleasanton, CA, has successfully closed a $1.8M seed round. Investors like Unorthodox Ventures, SCP Ventures, and WS Investment Company joined in, along with individual angel investors. The co... |
| 18.03.2024 | ConKay Medical Systems Raises $1.8M in Seed Funding | ConKay Medical Systems, a Pleasanton, CA-based medtech company, raised $1.8M in Seed funding.
Backers included Unorthodox Ventures, SCP Ventures, WS Investment Company, and individual angel investors.
The company intends to use the funds to... |
| 18.03.2024 | ConKay Medical Systems Closes $1.8M in Seed Round |
PLEASANTON, CA, ConKay Medical Systems, a medtech start-up company developing a unique device for treating patients suffering from valvular regurgitation, has closed an oversubscribed $1.8M seed round.
>> Click here for more fundin... |
| - | ConKay Medical Systems | “ABOUT — ConKay Medical Systems” |
Reviews 0
